Improving Thinking Skills in MS: What You Need to Know

Improving Thinking Skills in MS: What You Need to Know
Credibility
Interest
Key Takeaway

Controlling MS early can improve thinking skills over time.

What They Found

The study looked at how thinking skills changed in MS patients over two years. Most patients (about 77 out of 101) did not show any signs of disease activity during the study. Some patients got better at tests that measure thinking skills, like memory and attention, while a few got worse. Those who started with less disability saw the most improvement in their thinking skills. This suggests that keeping MS under control early on can help with brain function.

Who Should Care and Why

MS patients should care because this study shows that managing their condition can lead to better thinking abilities. Just like how watering a plant helps it grow, taking care of MS early can help the brain stay healthy. Caregivers can also benefit by understanding that their loved ones may improve cognitively if treatment is started early. Doctors can use this information to encourage patients to stick to their treatment plans. Overall, staying on top of MS can lead to a better quality of life.

Important Considerations

The study involved a specific group of 101 MS patients, so results may not apply to everyone. The improvements in thinking skills were not huge for all patients, showing that results can vary. It’s also important to note that factors outside of treatment may influence cognitive changes, so further research is needed.

Article Topics:
BICAMScognitive impairmenthigh‐efficacy therapymultiple sclerosis

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
CD29: A Blood Clue to MS B Cells and Treatment Response
CD29: A Blood Clue to MS B Cells and Treatment Response

5/1/2026

Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in

Read More
What MS Patients Should Know About PML and Recovery
What MS Patients Should Know About PML and Recovery

5/1/2026

Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes

Read More
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID
Fewer Hospital Cases of Certain Brain Autoimmunity During COVID

5/1/2026

Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b

Read More
New option to reduce damage in NMOSD attacks
New option to reduce damage in NMOSD attacks

3/1/2026

Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or

Read More
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart
Quick Eye Scan Helps Tell Two Serious Optic Nerve Conditions Apart

3/1/2026

Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like European journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.